• Explore /
  • Poster
  • / PIER trial: Neoadjuvant therapy with panitumumab (P) and mFOLFOX-6 in an enriched population of patients with T3 rectal adenocarcinoma of the middle third with clear mesorectal fascia.

PIER trial: Neoadjuvant therapy with panitumumab (P) and mFOLFOX-6 in an enriched population of patients with T3 rectal adenocarcinoma of the middle third with clear mesorectal fascia.

Abstract Poster

Authors

null

Carlos Fernandez-Martos

Fundacion Instituto Valenciano De Onclogia, Valencia, Spain

Carlos Fernandez-Martos , Jorge Aparicio , Juan Ayuso , Jaume Capdevila , Javier Gallego , Ferran Losa , Monique Maas , Joan Maurel , Carles Pericay , Nuria Rodriguez Salas , Maria Jose Safont , Maria Tobeña , Manuel Valladares , Ruth Vera

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 Gastrointestinal Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Cancers of the Colon, Rectum, and Anus

Sub Track

Multidisciplinary Treatment

Clinical Trial Registration Number

NCT03000374

Citation

J Clin Oncol 36, 2018 (suppl 4S; abstr TPS875)

DOI

10.1200/JCO.2018.36.4_suppl.TPS875

Abstract #

TPS875

Poster Bd #

Q3

Abstract Disclosures

Similar Posters

First Author: Carlos Fernandez-Martos

First Author: Takeshi Yamada

Poster

2023 ASCO Gastrointestinal Cancers Symposium

Mutation status of full <em>RAS</em> and <em>BRAF</em> in 169 Moroccan patients with colorectal cancer.

Mutation status of full RAS and BRAF in 169 Moroccan patients with colorectal cancer.

First Author: Sara El Zaitouni

First Author: Yoshihito Ohhara